☆ 4.6 Review

B Cells in Breast Cancer Pathology

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Single-cell and spatial transcriptome analyses revealed cell heterogeneity and immune environment alternations in metastatic axillary lymph nodes in breast cancer

Xiaofan Mao et al.

Summary: This study revealed the cell structures of both micro- and macroenvironments in breast cancer (BC), showing the differences in cell changes and interactions between tumor and normal tissue, lymph nodes, and peripheral blood cells. It also identified cell features and interactions that are associated with patient prognosis.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Add to Collection

Article Oncology

Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node

Ning Liao et al.

Summary: This study examined the host-tumor interaction in breast cancer nodal metastases at a single cell level. It found that the sentinel lymph node serves as the initial meeting site for tumor infiltration and immune response, with some T lymphocytes exhibiting anti-tumor activity and others in an exhausted state.

BREAST CANCER (2023)

Add to Collection

Article Oncology

B cell-related gene signature and cancer immunotherapy response

Arian Lundberg et al.

Summary: The study revealed that the prognostic impact of tumor-infiltrating B cells depends on the status of cytokine signaling genes, which can predict response to cancer immunotherapy.

BRITISH JOURNAL OF CANCER (2022)

Add to Collection

Article Oncology

First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study

Jian Zhang et al.

Summary: KN026, a novel bispecific antibody targeting two distinct HER2 epitopes, showed good safety and efficacy in monotherapy treatment of HER2-positive MBC patients, with potential predictive value in co-amplification of CDK12 as a biomarker for better treatment response.

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

Cell2location maps fine-grained cell types in spatial transcriptomics

Vitalii Kleshchevnikov et al.

Summary: Cell2location, a Bayesian model, can resolve the spatial distribution of cell types and create comprehensive cellular maps of tissues. By accounting for technical variation and borrowing statistical strength, cell2location has higher sensitivity and resolution than existing tools. Our results demonstrate that cell2location is a versatile analysis tool for mapping tissue architectures in a comprehensive manner.

NATURE BIOTECHNOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

P. Schmid et al.

Summary: The addition of pembrolizumab to neoadjuvant chemotherapy followed by adjuvant pembrolizumab after surgery significantly prolonged event-free survival in patients with early triple-negative breast cancer.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Review Immunology

Breast Cancer Vaccines: Disappointing or Promising?

Si-Yuan Zhu et al.

Summary: Breast cancer is the most commonly diagnosed cancer worldwide, with relapse and metastasis posing significant challenges. Innovative therapeutic strategies, such as cancer vaccines, are needed to address these challenges. Although current results have been disappointing, recent studies suggest the potential of combining vaccines with other treatments for breast cancer.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Oncology

Intratumor expanded T cell clones can be non-sentinel lymph node derived in breast cancer revealed by single-cell immune profiling

Shiping Jiao et al.

Summary: This study revealed expanded intratumor non-sentinel LN derived T cell clones, indicating the need to explore the role of TLS in antitumor immunity.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection

Review Oncology

Role of Fcγ receptors in HER2-targeted breast cancer therapy

Antonino Musolino et al.

Summary: Fc gamma R-mediated activities play a crucial role in the treatment of HER2+ breast cancer, but variations in Fc-gammaR can lead to differential therapeutic outcomes.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection

Article Medicine, General & Internal

Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer

Aleix Prat et al.

Summary: A new HER2DX risk score and pCR score have been developed to accurately predict survival and treatment response in early-stage HER2-positive breast cancer.

EBIOMEDICINE (2022)

Add to Collection

Review Rheumatology

Autoantibodies in Patients With Immune-Related Adverse Events From Checkpoint Inhibitors A Systematic Literature Review

Nilasha Ghosh et al.

Summary: Autoantibodies are sometimes associated with immune-related adverse events (irAEs) from immune checkpoint inhibitors (ICIs), but their presence before ICI initiation and their frequency were not known. This study found that autoantibodies were present in close to 50% of patients with ICI-associated endocrinopathies and more than 50% of patients with skin irAEs. However, the positivity rate of autoantibodies was lower in irAEs affecting other organ systems. There are mixed results regarding the utility of autoantibodies as biomarkers of irAEs.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Nano-trapping CXCL13 reduces regulatory B cells in tumor microenvironment and inhibits tumor growth

Limei Shen et al.

Summary: Interaction between different cell types in the tumor microenvironment affects tumor growth. Tumor-associated fibroblasts produce CXCL13, which recruits B cells to the tumor microenvironment. B cells in the tumor microenvironment differentiate into regulatory B cells (Bregs). CXCL13 also stimulates epithelial-mesenchymal transition (EMT) of tumor cells. Using plasmid DNA encoding a CXCL13 trap to reduce Bregs differentiation and normalize EMT suppresses tumor growth.

JOURNAL OF CONTROLLED RELEASE (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

SIA-IgG confers poor prognosis and represents a novel therapeutic target in breast cancer

Man Zhang et al.

Summary: Breast cancer has the highest incidence rate in the world, and therapy resistance of breast cancer stem cells (CSCs) poses a major challenge in clinical treatment. This study identifies SIA-IgG as a potential therapeutic target in breast cancer and investigates its functional changes and molecular mechanisms. The results provide a potential prognostic marker and a novel therapeutic target for breast cancer.

BIOENGINEERED (2022)

Add to Collection

Article Immunology

The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer

Bin Wang et al.

Summary: This study investigated the clinicopathological and prognostic significance of tertiary lymphoid structures (TLSs) in patients with breast cancer. The results showed that the presence of TLSs was associated with improved disease-free survival and overall survival, as well as with certain biomarkers. Additionally, breast cancer patients with a high TLS signature exhibited better survival outcomes.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

CXCL13-producing CD4+T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer

Masayo Ukita et al.

Summary: The formation of tertiary lymphoid structures (TLS) is associated with CXCL13-producing CD4+ T cells, and TLS facilitates the coordinated antitumor response of cellular and humoral immunity in ovarian cancer.

JCI INSIGHT (2022)

Add to Collection

Article Multidisciplinary Sciences

Single cell profiling of primary and paired metastatic lymph node tumors in breast cancer patients

Tong Liu et al.

Summary: This study characterizes the microenvironment of lymph node metastasized tumors (LNMT) and primary tumors (PT) in breast cancer. The results show that T cell activation, cytotoxicity, and proliferation are suppressed in LNMT compared to PT. CD4(+)CXCL13(+) T cells in LNMT are more likely to become exhausted. LAMP3(+) dendritic cells in LNMT have lower T cell priming and activating ability compared to PT. PLA2G2A(+) cancer-associated fibroblasts, enriched in HER2(+) breast cancer patients, promote immune infiltration. Additionally, the antigen-presentation pathway is downregulated in malignant cells of the metastatic lymph node.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Oncology

Artificial intelligence in digital pathology approach identifies the predictive impact of tertiary lymphoid structures with immune-checkpoints therapy in NSCLC.

Mehrdad Rakaee et al.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

14-gene immunoglobulin (IGG) and proliferation signatures and association with overall survival across cancer-types.

Francesco Schettini et al.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

B Lymphocytes Are a Predictive Marker of Eribulin Response and Overall Survival in Locally Advanced or Metastatic Breast Cancer: A Multicenter, Two-Cohort, Non-Randomized, Open-Label, Retrospective Study

Liubov A. Tashireva et al.

Summary: This study reveals that evaluating the composition of immune cells in the tumor microenvironment can predict the effectiveness of eribulin treatment and overall survival in patients with locally advanced or metastatic triple-negative breast cancer.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Oncology

Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatment

Jiehui Deng et al.

Summary: This study utilized single-cell RNA sequencing to analyze immune cell changes in two advanced TNBC patients undergoing different treatment stages, revealing heterogeneity in tumor-infiltrating immune cell populations and modulation of the tumor microenvironment by chemotherapy and immunotherapy. Notably, a responding patient showed a decrease in PD-1(high)-expressing T cells after chemo-immunotherapy, while a progressor demonstrated a prevalent and persistent myeloid compartment in the tumors.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Add to Collection

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Oncology

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer

Yuanyuan Zhang et al.

Summary: The study indicates that high levels of baseline CXCL13(+) T cells are associated with effective responses to combination therapy in triple-negative breast cancer patients. These cells increase following combination therapy but decrease after monotherapy, highlighting their importance in predicting treatment outcomes.

CANCER CELL (2021)

Add to Collection

Article Immunology

B cells and cancer: To B or not to B?

Wolf Herman Fridman et al.

Summary: Recent studies have suggested that B cells in the tumor microenvironment may play a significant role in presenting tumor-associated antigens to T cells and producing antibodies that enhance antigen presentation, ultimately impacting cancer clinical outcomes. Immune complexes formed by B cells can also have deleterious effects through inflammation, angiogenesis, and immunosuppression via macrophage and complement activation.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Cancer-Cell-Derived IgG and Its Potential Role in Tumor Development

Said Kdimati et al.

Summary: Human immunoglobulin G (IgG) is the primary component of human serum antibody fraction, with different subclasses having unique physiological functions through binding to different IgG-Fc receptors. Recent discoveries suggest that IgG expressed in tumor cells may promote cancer progression and could potentially be targeted for therapeutic purposes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Cell Biology

Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications

Maria Vittoria Dieci et al.

Summary: TILs play a significant role in BC prognosis and treatment, especially showing strong prognostic effects in triple-negative BC patients.

CELLS (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Integrative analyses of scRNA-seq and scATAC-seq reveal CXCL14 as a key regulator of lymph node metastasis in breast cancer

Kun Xu et al.

Summary: This study revealed the cellular and molecular mechanisms of breast cancer lymph node metastasis using single-cell RNA sequencing and chromatin accessibility sequencing, identifying a novel cell subpopulation with aberrantly high expression of CXCL14 in lymph node metastases. Validation through tissue microarray and database analysis confirmed the significance of CXCL14 in lymph node metastasis of breast cancer. Additionally, potential regulatory transcription factors were identified through scATAC-seq for breast cancer lymph node metastasis.

HUMAN MOLECULAR GENETICS (2021)

Add to Collection

Article Oncology

Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer

Hajime Kuroda et al.

Summary: The study showed that a high density of sCD20 + TILs was significantly associated with favorable prognosis in both RFS and OS, while increased sCD38 + TILs in TNBC correlated with a significantly favorable prognosis in RFS. On the other hand, iCD38, iCD138, and sCD138 were not significantly correlated with RFS or OS in TNBC patients.

BREAST CANCER (2021)

Add to Collection

Article Multidisciplinary Sciences

Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions

Alma Andersson et al.

Summary: This study utilized Spatial Transcriptomics technology to investigate gene expression in HER2-positive breast tumors, identifying shared gene signatures for immune and tumor processes and developing a predictive model for cellular interactions.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Oncology

The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy

Vincenzo Salemme et al.

Summary: The progression of breast cancer is influenced by genetic and epigenetic factors that involve interactions between tumor cells and the tumor microenvironment, particularly immune cells. Immune cells in the tumor microenvironment can have dual roles in cancer onset and progression, affecting both tumor suppression and promotion. Understanding the complex interplay between cancer and immune cells, as well as therapeutic strategies targeting this interaction, is crucial for developing effective combination treatments to overcome tumor immune evasion mechanisms and maximize the clinical benefits of current immunotherapies.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in BRCA1 Mutation

Li Hu et al.

Summary: This study reveals that breast cancer in BRCA1 mutation carriers may originate from luminal cells and abnormal luminal progenitor cells in normal tissues may contribute to the development of basal-like tumors. Additionally, ERhigh luminal breast cancer may stem from mature luminal cells.

CANCER RESEARCH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast

Bhupinder Pal et al.

Summary: Global changes in breast heterogeneity were examined across different states through single-cell transcriptome analysis, revealing notable variations in the stroma of post-menopausal women and a discrete subset of cycling cells in tumor samples. Comparison between preneoplastic BRCA1(+/-) tissue and tumors highlighted global changes in the immune microenvironment. Proliferative CD8(+) T cells were found to characterize certain breast cancer subtypes, suggesting potential differences in immunotherapy targets.

EMBO JOURNAL (2021)

Add to Collection

Article Oncology

Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis

Kun Xu et al.

Summary: This study utilized single-cell sequencing to analyze the transcriptome profile of breast cancer lymph node metastasis, identifying key breast cancer stem cells and their evolution, as well as revealing the interactions between breast cancer cells and tumor microenvironment cells.

ONCOGENESIS (2021)

Add to Collection

Article Oncology

Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer

Angela Quintana et al.

Summary: Only a small percentage of TNBC patients have high levels of TILs, while another portion lacks TILs. The low levels of TILs at diagnosis may be due to lymphocytes being deactivated by immune checkpoints in local lymph nodes, preventing migration to the tumor.

EUROPEAN JOURNAL OF CANCER (2021)

Add to Collection

Article Cell Biology

Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1-PD-L1+ Bregs through PD-L1/PI3K/AKT/NF-κB axis in breast cancer

Min Liu et al.

Summary: MDSCs activate the PI3K/AKT/NF-kappa B pathway in B cells via the PD-1/PD-L1 axis, regulating the immunosuppressive function of Bregs. Inhibition of PD-1/PD-L1 or PI3K/AKT signaling suppresses tumor growth and the immunosuppressive functions of Bregs. Dual suppression of PD-1/PD-L1 and PI3K/AKT shows better antitumor effect.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Multidisciplinary Sciences

Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling

Qingtao Hu et al.

Summary: Characterization of tumor-infiltrated B cells in breast tumors through single-cell RNA sequencing and antigen receptor analysis reveals significant heterogeneity and features of infiltrated B cells. Results suggest local differentiation of infiltrated B cells within breast tumors. B cell signatures based on single-cell RNA sequencing results are associated with survival in breast tumor patients.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Oncology

Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers

Niclas C. Blessin et al.

Summary: Expansion of CD8(+) cytotoxic T lymphocytes plays a crucial role in anti-cancer immune activity, with varying impact on tumor prognosis depending on the tumor type. In colorectal and renal cell cancer, proliferating CD8(+) T cells are associated with favorable tumor parameters and prolonged overall survival, while in breast, ovarian, pancreatic and gastric cancer their role is not linked to clinicopathological data.

CELLULAR ONCOLOGY (2021)

Add to Collection

Article Oncology

Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer

Robert J. Harris et al.

Summary: In triple-negative breast cancer, tumor-infiltrating B lymphocytes form clusters and undergo activation, proliferation, and isotype switching driven by the B-cell receptor. Clonally expanded, IgG isotype-biased humoral immunity in TNBC is associated with favorable prognosis.

CANCER RESEARCH (2021)

Add to Collection

Meeting Abstract Oncology

Preliminary results from a phase 1/2 study of BDC-1001, a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), in patients (pts) with advanced HER2-expressing solid tumors.

Manish Sharma et al.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Review Oncology

Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response

Tong Fu et al.

Summary: Tumors are not only collections of malignant cells, but also organized complex ecosystems. With the emergence of innovative technologies, researchers can more accurately understand the spatial architecture of the tumor immune microenvironment (TIME), improving our knowledge of tumor biology. The spatial architecture of TIME plays a crucial role in tumor biology and is influenced by the gradient of extracellular nonspecific chemicals (ENSCs).

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Add to Collection

Article Genetics & Heredity

A single-cell and spatially resolved atlas of human breast cancers

Sunny Z. Wu et al.

Summary: This study presents a comprehensive transcriptional atlas of the cellular architecture of breast cancer, identifying recurrent neoplastic cell heterogeneity and new immune cell populations associated with clinical outcomes. A multi-omic atlas integrates single-cell RNA sequencing, spatial transcriptomics, and immunophenotyping to stratify breast cancer into nine ecotypes with unique cellular compositions and clinical outcomes.

NATURE GENETICS (2021)

Add to Collection

Article Multidisciplinary Sciences

Tertiary lymphoid structures (TLS) identification and density assessment on H&E-stained digital slides of lung cancer

Panagiotis Barmpoutis et al.

Summary: This study introduces a new method for automated identification and quantification of TLS on H&E tissue slides, with mathematical criteria defining TLS and utilizing deep learning networks and an ellipsoidal model for segmentation. The research shows that the density of lymphocytes within TLS regions is more than 3 times that of non-TLS regions.

PLOS ONE (2021)

Add to Collection

Article Oncology

Spatial distribution of B cells and lymphocyte clusters as a predictor of triple-negative breast cancer outcome

Juliana C. Wortman et al.

Summary: The study highlights the importance of spatial distribution of B cells and LCs within tumors for prognosis, showing that in good outcome tumors, B cells and LCs are more abundant and more spatially dispersed.

NPJ BREAST CANCER (2021)

Add to Collection

Article Oncology

Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication

Fangfang Liu et al.

Summary: This study reveals the correlation between TILs and germinal center formation with the prognosis of breast cancer patients, emphasizing the importance of assessing immune responses in both primary and lymph node sites for future research.

NPJ BREAST CANCER (2021)

Add to Collection

Article Oncology

Plasma cell infiltration and treatment effect in breast cancer patients treated with neoadjuvant chemotherapy

Asumi Sakaguchi et al.

Summary: This study found that higher levels of plasma cells (PCs) infiltration in biopsy specimens before neoadjuvant chemotherapy were associated with pathological complete response (pCR). Through multiplexed fluorescent immunohistochemistry (mfIHC), it was also revealed that the local cytotoxic immune response was enhanced in pCR cases, with increased infiltration of B cells including PCs. Furthermore, higher levels of PCs were correlated with favorable outcomes in hormone receptor-negative breast cancer patients.

BREAST CANCER RESEARCH (2021)

Add to Collection

Article Oncology

Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies

N. Jacquelot et al.

Summary: Tertiary lymphoid structures (TLS) are ectopic cellular aggregates resembling secondary lymphoid organs. Found in solid tumors, TLS exhibit varying degrees of maturation and are composed of diverse immune cell types that actively drive the immune response against tumor development and progression. Their role, prognostic value, and potential for immunotherapeutic targeting are discussed in this review.

ONCOIMMUNOLOGY (2021)

Add to Collection

Article Oncology

Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy

Carmine De Angelis et al.

CLINICAL CANCER RESEARCH (2020)

Add to Collection

Article Medicine, General & Internal

Pembrolizumab for Early Triple-Negative Breast Cancer

Peter Schmid et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Cell Biology

T Cell Dysfunction and Exhaustion in Cancer

Zhen Zhang et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity

Yiwen Lu et al.

CELL (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task

Guoying Ni et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Stromal cell diversity associated with immune evasion in human triple-negative breast cancer

Sunny Z. Wu et al.

EMBO JOURNAL (2020)

Add to Collection

Article Multidisciplinary Sciences

Cellular heterogeneity map of diverse immune and stromal phenotypes within breast tumor microenvironment

Yuan Li et al.

PEERJ (2020)

Add to Collection

Article Medicine, Research & Experimental

The balance of regulatory and stimulatory B cell subsets in breast cancer draining lymph nodes correlates with tumor prognostic factors

Sahar Shariati et al.

LIFE SCIENCES (2020)

Add to Collection

Article Multidisciplinary Sciences

A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas

Claudio Tripodo et al.

ISCIENCE (2020)

Add to Collection

Article Oncology

Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis

Zhao-hua Gao et al.

BMC CANCER (2020)

Add to Collection

Article Medicine, General & Internal

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortes et al.

LANCET (2020)

Add to Collection

Article Multidisciplinary Sciences

Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure

Ziying Lin et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Oncology

Single-Cell RNA Sequencing of a Postmenopausal Normal Breast Tissue Identifies Multiple Cell Types That Contribute to Breast Cancer

Sen Peng et al.

CANCERS (2020)

Add to Collection

Review Oncology

Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm

Giuseppe Luigi Banna et al.

ONCOLOGY REVIEWS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Tumour-Infiltrating Inflammatory Cells in Early Breast Cancer: An Underrated Prognostic and Predictive Factor?

Soeren Schnellhardt et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Oncology

Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial

Cornelia Kolberg-Liedtke et al.

BREAST CANCER RESEARCH (2020)

Add to Collection

Letter Rheumatology

Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1

Andrew L. Mammen et al.

ANNALS OF THE RHEUMATIC DISEASES (2019)

Add to Collection

Review Oncology

St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment

Marija Balic et al.

BREAST CARE (2019)

Add to Collection

Article Oncology

Coexistence of regulatory B cells and regulatory T cells in tumor-infiltrating lymphocyte aggregates is a prognostic factor in patients with breast cancer

Emi Ishigami et al.

BREAST CANCER (2019)

Add to Collection

Meeting Abstract Oncology

Impact of chemotherapy-induced ovarian failure (CIOF) on disease-free survival (DFS) and overall survival (OS) in young women with early breast cancer (EBC)

J. Furlanetto et al.

ANNALS OF ONCOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer

Daniel P. Hollern et al.

CELL (2019)

Add to Collection

Review Oncology

Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors

Satya Das et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Add to Collection

Article Oncology

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

Sherene Loi et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG

Yan Gu et al.

NATURE MEDICINE (2019)

Add to Collection

Article Medicine, Research & Experimental

Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer

Soizic Garaud et al.

JCI INSIGHT (2019)

Add to Collection

Article Oncology

Impact of Number of Positive Lymph Nodes and Lymph Node Ratio on Survival of Women with Node-Positive Breast Cancer

Fabiana Tonellotto et al.

EUROPEAN JOURNAL OF BREAST HEALTH (2019)

Add to Collection

Article Oncology

B-cell populations are expanded in breast cancer patients compared with healthy controls

Banri Tsuda et al.

BREAST CANCER (2018)

Add to Collection

Article Oncology

The combined presence of CD20+B cells and PD-L1+tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome

H. Arias-Pulido et al.

BREAST CANCER RESEARCH AND TREATMENT (2018)

Add to Collection

Article Oncology

Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node

Jonathan R. McDaniel et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment

Elham Azizi et al.

CELL (2018)

Add to Collection

Article Cell Biology

Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance

Maryam Althobiti et al.

HISTOPATHOLOGY (2018)

Add to Collection

Article Medicine, Research & Experimental

Early B cell changes predict autoimmunity following combination immune checkpoint blockade

Rituparna Das et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Add to Collection

Article Gastroenterology & Hepatology

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors

Eleonora De Martin et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Article Oncology

Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast

Yangmei Xu et al.

TUMORI JOURNAL (2018)

Add to Collection

Article Immunology

High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer

Joe Yeong et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Oncology

A novel MDSC-induced PD-1(-)PD-L1(+) B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties

Meng Shen et al.

ONCOIMMUNOLOGY (2018)

Add to Collection

Article Oncology

Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast

Yangmei Xu et al.

TUMORI JOURNAL (2018)

Add to Collection

Article Immunology

Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced in situ by Tumor-Infiltrating B Cells in Breast Cancer

Soizic Garaud et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Review Immunology

Long-Lived Plasma Cells in Mice and Men

Siggeir F. Brynjolfsson et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Pathology

Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node-positive breast cancers

Anita Grigoriadis et al.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2018)

Add to Collection

Article Oncology

CD40-activated B cells induce anti-tumor immunity in vivo

Kerstin Wennhold et al.

ONCOTARGET (2017)

Add to Collection

Article Cell Biology

Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ

Islam Miligy et al.

HISTOPATHOLOGY (2017)

Add to Collection

Article Oncology

Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer

In Hye Song et al.

CANCER RESEARCH AND TREATMENT (2017)

Add to Collection

Review Pathology

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

Shona Hendry et al.

ADVANCES IN ANATOMIC PATHOLOGY (2017)

Add to Collection

Article Pathology

Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer

Hee Jin Lee et al.

JOURNAL OF CLINICAL PATHOLOGY (2016)

Add to Collection

Article Oncology

Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer

Rashmi Verma et al.

BREAST CANCER RESEARCH (2016)

Add to Collection

Article Immunology

Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10

Huimin Tao et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs

Francesca Barone et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Add to Collection

Review Oncology

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

R. Salgado et al.

ANNALS OF ONCOLOGY (2015)

Add to Collection

Article Oncology

Multiplexed Quantitative Analysis of CD3, CD8, and CD20 Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer

Jason R. Brown et al.

CLINICAL CANCER RESEARCH (2014)

Add to Collection

Article Immunology

TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance

Kang Mi Lee et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2014)

Add to Collection

Article Immunology

Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation

Masanori Matsumoto et al.

IMMUNITY (2014)

Add to Collection

Article Medicine, Research & Experimental

CD4+ follicular helper T cell infiltration predicts breast cancer survival

Chunyan Gu-Trantien et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Add to Collection

Article Multidisciplinary Sciences

Correlation of Immunoglobulin G Expression and Histological Subtype and Stage in Breast Cancer

Baokai Yang et al.

PLOS ONE (2013)

Add to Collection

Review Immunology

Germinal Centers

Gabriel D. Victora et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)

Add to Collection

Article Oncology

The prognostic significance of B lymphocytes in invasive carcinoma of the breast

S. M. A. Mahmoud et al.

BREAST CANCER RESEARCH AND TREATMENT (2012)

Add to Collection

Review Oncology

The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer

Zahra M. A. Mohammed et al.

CANCER TREATMENT REVIEWS (2012)

Add to Collection

Article Immunology

The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry

David Dominguez-Sola et al.

NATURE IMMUNOLOGY (2012)

Add to Collection

Article Immunology

The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers

Dinis Pedro Calado et al.

NATURE IMMUNOLOGY (2012)

Add to Collection

Article Multidisciplinary Sciences

Leukocyte composition of human breast cancer

Brian Ruffell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Add to Collection

Article Oncology

Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells

Purevdorj B. Olkhanud et al.

CANCER RESEARCH (2011)

Add to Collection

Article Oncology

Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer

Ludovic Martinet et al.

CANCER RESEARCH (2011)

Add to Collection

Article Oncology

Adoptive Transfer of Tumor Reactive B Cells Confers Host T-Cell Immunity and Tumor Regression

Qiao Li et al.

CLINICAL CANCER RESEARCH (2011)

Add to Collection

Review Immunology

Treg cell-IgA axis in maintenance of host immune homeostasis with microbiota

Ting Feng et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2011)

Add to Collection

Article Immunology

CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

Paul A. Blair et al.

IMMUNITY (2010)

Add to Collection

Article Immunology

PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells

Kim L. Good-Jacobson et al.

NATURE IMMUNOLOGY (2010)

Add to Collection

Article Immunology

Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs

CM Sun et al.

IMMUNITY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.